bromebric acid: major descriptor (74-86); on line search ACRYLATES (74-86); INDEX MEDICUS search BROMEBRIC ACID (74-86); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 5358572 |
CHEMBL ID | 2106594 |
CHEBI ID | 135179 |
SCHEMBL ID | 2110065 |
MeSH ID | M0263162 |
Synonym |
---|
mbba (free acid) |
nsc-265480 |
5711-40-0 |
nsc265480 |
(e)-3-p-anisoyl-3-bromoacrylic acid |
bromebric acid |
2-butenoic acid, 3-bromo-4-(4-methoxyphenyl)-4-oxo-, sodium salt, (e)- |
(e)-3-bromo-4-(4-methoxyphenyl)-4-oxo-but-2-enoic acid |
cytembena |
bromebric acid [inn:ban] |
acidum bromebricum |
acide bromebrique |
nsc 104801 |
(e)-3-p-anisoyl-3-bromacrylsaeure |
bromebrinsaeure |
acido bromebrico |
CHEBI:135179 |
HMS2089L16 |
cas-5711-40-0 |
dtxsid9046231 , |
dtxcid7026231 |
tox21_111900 |
fge8818gwa , |
unii-fge8818gwa |
bromebric acid [inn] |
(e)-3-(p-anisoyl)-3-bromoacrylic acid |
2-butenoic acid, 3-bromo-4-(4-methoxyphenyl)-4-oxo-, (2e)- |
CHEMBL2106594 |
DL-221 |
SCHEMBL2110065 |
sr-05000001481 |
SR-05000001481-1 |
bromebric |
bromebricacid |
Q27277977 |
Excerpt | Reference | Relevance |
---|---|---|
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs." | ( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019) | 0.51 |
Class | Description |
---|---|
carbonyl compound | Any compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
TDP1 protein | Homo sapiens (human) | Potency | 16.2582 | 0.0008 | 11.3822 | 44.6684 | AID686978; AID686979 |
AR protein | Homo sapiens (human) | Potency | 26.0622 | 0.0002 | 21.2231 | 8,912.5098 | AID743042; AID743054; AID743063 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 11.0581 | 0.0002 | 29.3054 | 16,493.5996 | AID743069; AID743075; AID743077; AID743078; AID743080; AID743091 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 8.4852 | 0.0010 | 19.4141 | 70.9645 | AID743094; AID743140 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 29.8493 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 12.7755 | 0.0023 | 19.5956 | 74.0614 | AID651631; AID720552 |
ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 10.7981 | 0.0119 | 17.9420 | 71.5630 | AID651632; AID720516 |
Ataxin-2 | Homo sapiens (human) | Potency | 10.5909 | 0.0119 | 12.2221 | 68.7989 | AID651632 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1 | Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5 | A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 10 (76.92) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (7.14%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (92.86%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |